CYRIANCE
LIVE

Serial Number

79260613

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 8, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CYRIANCE Trademark

Serial Number: 79260613 • Registration: 5899882

CYRIANCE is a trademark filed by NOVARTIS AG on May 8, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 8, 2019

Registration Date

November 5, 2019

Published for Opposition

August 20, 2019

Cancellation Date

December 15, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jan 2, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jan 2, 2023 DETH
NOTIFICATION PROCESSED BY IB
Jan 24, 2020 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jan 4, 2020 FICS
FINAL DISPOSITION PROCESSED
Jan 4, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Dec 5, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Nov 5, 2019 R.PR
PUBLISHED FOR OPPOSITION
Aug 20, 2019 PUBO
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 8, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 8, 2019 REAP
NOTICE OF PUBLICATION
Jul 31, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2019 CNSA
ASSIGNED TO EXAMINER
Jul 6, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 5, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 26, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 13, 2019 REPR